SABCS 2011 CLEOPATRA A phase III, randomized, double-blind, placebo-controlled registration trial to evaluate the efficacy and safety of pertuzumab + trastuzumab ...
... Presentation PowerPoint Presentation PowerPoint Presentation PowerPoint Presentation Breast conservation without radiotherapy Breast conservation without ...
Opportunities that the current political climate offers developmental journalism ... Not restricting access to news sources. ... a plurality of views and news. ...
Title: HER Education Network Author: brohling Last modified by: Administrator Created Date: 7/11/2003 3:47:23 PM Document presentation format: On-screen Show
1. SABC's Funding Model Options for the Future. Justine Limpitlaw. Media ... controversial, devil's advocate, puts the cat among the pigeons, stir debate etc ...
A Report from SABCS Up-to-Date Review of the Treatment of Early Breast Cancer Maura N. Dickler, MD Assistant Attending Physician Breast Cancer Medicine Service
... within the governance itself, politics will find a way to ... Presidential appointment: 1. Ministerial appointment (Department of Communications): 1 ...
Title: Zoom SABCS 2010 Author: La Lettre du Canc rologue Last modified by: Charles DUFRENE Created Date: 10/12/2010 10:52:17 AM Document presentation format
Baselga J et al. SABCS 2009;Abstract 45. Introduction Phase III trial of capecitabine (CAP) combined with anti-VEGF agent bevacizumab demonstrated an improved ...
Title: Main Title Slide Always use Title Case on Slide Titles Author: Fernando G Rendina Last modified by: Albert Rosado Created Date: 12/17/2009 7:27:13 PM
Title: Research To Practice Created Date: 12/21/2012 6:13:07 PM Document presentation format: On-screen Show (4:3) Other titles: Arial MS P Verdana ...
Trastuzumab plus Adjuvant Chemotherapy for HER2-Positive Breast Cancer: Final Planned Joint Analysis of Overall Survival from NSABP B-31 and NCCTG N9831
Title: Research To Practice Created Date: 12/21/2012 6:13:07 PM Document presentation format: On-screen Show (4:3) Other titles: Arial MS P Verdana ...
An Interactive Webcast Featuring Discussion of Key Presentations and Posters from the 2011 San Antonio ... and Fulvestrant as First-Line ... Trial to Evaluate ...
A Double-Blind, Randomized, Placebo-Controlled Trial of High-Dose Vitamin D Therapy on Musculoskeletal Pain and Bone Mineral Density in Anastrozole-Treated Breast ...
A Double-Blind, Randomized Phase 2b Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo when Administered in Combination with Paclitaxel in ...
Sporadic triple-negative breast ... + three patients with saline expanders and one with silicone implant; NS ... Reconstruction-related complications trended ...
Node-Negative, ER-Positive Breast Cancer Using the Recurrence Score and RSPC, a New Measure Integrating Clinical and Pathologic Data with the Recurrence Score
Phase III Trial Evaluating the Addition of Bevacizumab to Endocrine Therapy as First-Line Treatment for Advanced Breast Cancer First Efficacy Results from the LEA ...
Title: Research To Practice Author: Fernando G Rendina Last modified by: Fernando Rendina Created Date: 5/20/2009 1:19:04 AM Document presentation format
Discussion Topics HER2 positive disease Growing number of options Angiogenesis Bevacizumab questions answered and rephrased Small molecule success and ...
... Drugs 2012 Ongoing trial of non HER-2 targeted agents Sharial et al, Ann Oncol 2012 PI3K pathway mTOR and PI3K inhibitors Phase I/II study X2107: ...
Title: Research To Practice Author: Fernando G Rendina Last modified by: Fernando Rendina Created Date: 5/20/2009 1:19:04 AM Document presentation format
Introduction Phase III US Oncology Research trial 9735 demonstrated that docetaxel/cyclophosphamide ... and there were no cases of clinical congestive heart failure.
Title: Main Title Slide Always use Title Case on Slide Titles Author: Fernando G Rendina Last modified by: Aura Herrmann Created Date: 5/20/2009 1:19:04 AM
Title: Research To Practice Author: Fernando G Rendina Last modified by: Fernando Rendina Created Date: 3/16/2011 3:16:53 AM Document presentation format
Integration of Capecitabine into Anthracycline- and Taxane-Based Adjuvant Therapy for Triple Negative Early Breast Cancer: Final Subgroup Analysis of the FinXX Study1
Effect of Denosumab versus Zoledronic Acid Treatment in Patients with Breast Cancer and Bone ... breast cancer and bone metastasis reported an 18 percent ...
Title: Research To Practice Author: Fernando G Rendina Last modified by: Fernando Rendina Created Date: 5/20/2009 1:19:04 AM Document presentation format
HERA TRIAL: 2 Years versus 1 Year of Trastuzumab After Adjuvant Chemotherapy in Women with HER2-Positive Early Breast Cancer at 8 Years of Median Follow-Up
... / Metastatic Breast Cancer ... no concomitant endocrine therapy No uncontrolled ... Conclusions The addition of bevacizumab to neoadjuvant therapy for patients ...
Sensitivity to PARP inhibitors was assessed by: Cell proliferation assays (XTT ... BRCA1 promoter methylation may be assessed as a biomarker of response in current ...
The Impact of Body Mass Index (BMI) on the Efficacy of Adjuvant Endocrine Therapy in Postmenopausal Hormone Sensitive Breast Cancer Patients; Exploratory Analysis ...
Essai AGO de phase III comparant une chimioth rapie dose-dense s quentielle par ... (ETC) une chimioth rapie conventionnelle chez les patientes avec ...
The Effect of Zoledronic Acid (ZOL) on Aromatase Inhibitor-Associated Bone Loss in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole:
Title: Table ronde : analyse de la litt rature Author: hardy Last modified by: PAVEAU V ronique Created Date: 3/28/2008 4:47:52 PM Document presentation format
Roch H et al J Clin Oncol 2006. PACS-01: DFS in different subgroups (Forest plot analysis) ... Roch H et al J Clin Oncol 2006. ECTO Study. Gianni L, et al, ...
Title: Research To Practice Author: Fernando G Rendina Last modified by: Fernando Rendina Created Date: 5/20/2009 1:19:04 AM Document presentation format